| Product Name | MF | CAS | Details |
|---|
| (2S,4S)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate | C11H20N2O4 | 121148-01-4 | Details |
| Orelabrutinib | C26H25N3O3 | 1655504-04-3 | Details |
| GS-6207 | C39H32ClF10N7O5S2 | 2189684-44-2 | Details |
| 2,3-dihydro-1-oxo-1H-indene-4-carbonitrile | C10H7NO | 60899-34-5 | Details |
| Lenvatinib | C21H19ClN4O4 | 417716-92-8 | Details |
| Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
| 1-oxo-2,3-dihydro-1H-indene-4-carboxamide | C10H9NO2 | 1391035-39-4 | Details |
| 5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID | C5H7NO3 | 30948-17-5 | Details |
| PF-04965842(Abrocitinib) | C14H21N5O2S | 1622902-68-4 | Details |
| METHYL 5-OXOPYRROLIDINE-3-CARBOXYLATE | C6H9NO3 | 35309-35-4 | Details |
| (E)-Oct-4-ene-1,8-dioic acid | C8H12O4 | 48059-97-8 | Details |
| 3-Pyrrolidinecarboxylicacid,5-oxo-,methylester,(3R)-(9CI) | C6H9NO3 | 443304-03-8 | Details |
| 2247995-37-3 | C30H34N8O3.CH4O3S | 2247995-37-3 | Details |
| (3R)-5-oxo-3-Pyrrolidinecarboxylic acid | C5H7NO3 | 428518-37-0 | Details |
| (R)-(-)-1-Aminoindan | C9H11N | 10277-74-4 | Details |
| Fruquintinib|HMPL-013 | C21H19N3O5 | 1194506-26-7 | Details |
| 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one | C15H19N5O | 1792180-81-4 | Details |
| 5-Chloropyrimidine-2-Carboxylic Acid Methyl Ester | C6H5ClN2O2 | 894797-00-3 | Details |
| (2R,4S)-1-tert-Butyl 2-methyl 4-aminopyrrolidine-1,2-dicarboxylate | C11H20N2O4 | 254881-77-1 | Details |
| methyl 6-chloropyrimidine-4-carboxylate | C6H5ClN2O2 | 6627-22-1 | Details |
| Methyl 5-fluoropyriMidine-2-carboxylate | C6H5FN2O2 | 1227575-47-4 | Details |
| Solifenacin succinate | C27H32N2O6 | 242478-38-2 | Details |
| 1-OXO-INDAN-4-CARBOXYLIC ACID | C10H8O3 | 56461-20-2 | Details |
| Ozanimod | C23H24N4O3 | 1306760-87-1 | Details |
| 1-NAPHTHOIC ACID METHYL ESTER | C12H10O2 | 2459-24-7 | Details |
| Dasatinib | C22H26ClN7O2S | 302962-49-8 | Details |
| 3-Pyrrolidinecarboxylicacid,5-oxo-,methylester,(3S)-(9CI) | C6H9NO3 | 428518-31-4 | Details |
| N-Boc-trans-4-amino-L-proline methyl ester | C11H20N2O4 | 121148-00-3 | Details |
| Upadacitinib | C17H19F3N6O | 1310726-60-3 | Details |
| PRN1008 | C36H40FN9O3 | 1575596-29-0 | Details |
| 1-NAPHTHALENEMETHYLAMINE | C11H11N | 118-31-0 | Details |
| Cabozantinib | C28H24FN3O5 | 849217-68-1 | Details |
| 1H-Indene-4-carboxylic acid, 2,3-dihydro-1-oxo-, Methyl ester | C11H10O3 | 55934-10-6 | Details |
| Axitinib | C22H18N4OS | 319460-85-0 | Details |
| Methyl 6-HydroxypyriMidine-4-carboxylate | C6H6N2O3 | 7399-93-1 | Details |
| Baricitinib | C16H17N7O2S | 1187594-09-7 | Details |
| Osimertinib mesylate | C29H37N7O5S | 1421373-66-1 | Details |
| METHYL (1S)-1-AMINOINDANE-4-CARBOXYLATE | C11H13NO2 | 1213699-80-9 | Details |
| (3R,5R)-5-methylpiperidin-3-amine | C6H14N2 | 1413370-59-8 | Details |
| (S)-(+)-1-Aminoindan | C9H11N | 61341-86-4 | Details |
| Lazertinib | C30H34N8O3 | 1903008-80-9 | Details |
| PIVMECILLINAM | C21H33N3O5S | 32886-97-8 | Details |
| 1,2-Pyrrolidinedicarboxylic acid, 4-amino-, 1-(1,1-dimethylethyl) 2-methyl ester, (2S)- | C11H20N2O4 | 1884703-99-4 | Details |
| Methyl (2R,4R)-1-Boc-4-aMinopyrrolidine-2-carboxylate | C11H20N2O4 | 1146160-08-8 | Details |
| Entrectinib | C31H34F2N6O2 | 1108743-60-7 | Details |
| (R)-tert-butyl (4-cyano-2,3-dihydro-1H-inden-1-yl)carbamate | C15H18N2O2 | 1306763-30-3 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 | ||||